蒙諾安敏注射液

Pajjiż: Tajwan

Lingwa: Ċiniż

Sors: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingredjent attiv:

ARGININE HCL L-;;L-THREONINE;;HISTIDINE L- HCL MONOHYDRATE;;L-TRYPTOPHAN;;MAGNESIUM ION;;PYRIDOXINE HCL;;L-PROLINE;;L-ISOLEUCINE;;ACETATE;;CHLORIDE ION;;GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL);;RIBOFLAVIN (VIT B2);;LYSINE L- HCL ( EQ TO L-LYSINE HCL);;XYLITOL;;MALIC ACID L-;;L-METHIONINE;;L-VALINE;;SODIUM ION;;INOSITOL (MESO-INOSITOL);;POTASSIUM ION;;ASPARTIC ACID DL-;;L-LEUCINE;;NIACINAMIDE (NICOTINAMIDE);;L-PHENYLALANINE;;L-ALANINE

Disponibbli minn:

公盟企業有限公司 高雄巿新興區漢民里新興路６８號 (83720928)

Għamla farmaċewtika:

注射劑

Kompożizzjoni:

XYLITOL (4020001900) 50GM; L-ALANINE (4020100202) 6.0GM; ARGININE HCL L- (4020100312) 3.0GM; ASPARTIC ACID DL- (4020100403) 0.5GM; HISTIDINE L- HCL MONOHYDRATE (4020100922) 0.8GM; L-ISOLEUCINE (4020101002) 0.7GM; L-LEUCINE (4020101202) 1.1GM; LYSINE L- HCL ( EQ TO L-LYSINE HCL) (4020101312) 1.1GM; L-METHIONINE (4020101502) 1.1GM; L-PHENYLALANINE (4020101702) 1.1GM; L-PROLINE (4020101802) 1.5GM; L-THREONINE (4020102002) 0.5GM; L-TRYPTOPHAN (4020102102) 0.3GM; L-VALINE (4020102302) 0.8GM; GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL) (4020102400) 7.5GM; ACETATE (4026000100) (35.3MEQ) 2.083GM; CHLORIDE ION (4026000510) (53.3MEQ) 1.889GM; MAGNESIUM ION (4026001110) (4.9MEQ) 0.060GM; POTASSIUM ION (4026001510) (24.1MEQ) 0.945GM; SODIUM ION (4026001710) (35.3MEQ) 0.811GM; NIACINAMIDE (NICOTINAMIDE) (8810000300) 0.1GM; RIBOFLAVIN (VIT B2) (8810200400) 4MG; PYRIDOXINE HCL (8810600300) 30MG; INOSITOL (MESO-INOSITOL) (8813000100) 0.5GM; MALIC ACID L- (9600017802) 3.0GM

Unitajiet fil-pakkett:

瓶裝

Klassi:

製　劑

Tip ta 'preskrizzjoni:

限由醫師使用

Manifatturat minn:

SCHIWA GMBH P.O.B0X 1180 4519GLANDROFF DE

Indikazzjonijiet terapewtiċi:

體內蛋白質缺乏症、燒傷、急性發熱及中毒現象、惡病體質、懷孕期嘔吐

Sommarju tal-prodott:

註銷日期: 1987/03/24; 註銷理由: 有效期間已屆未能補件; 有效日期: 1985/07/13; 英文品名: AMINOACIN L300

L-istatus ta 'awtorizzazzjoni:

已註銷

Data ta 'l-awtorizzazzjoni:

1976-07-13